A major focus of the Hattangadi-Gluth Lab is on the use of advanced MRI techniques to improve the quality and deliver of the radiotherapeutic treatment of brain tumors and the utilization of novel imaging biomarkers to measure treatment response. Dr. Hattangadi-Gluth is currently prospectively following brain tumor patients on a longitudinal study of advanced diffusion imaging and analyzing patient neurocognitive outcomes. A second major focus of her lab is on medical ethics, specifically financial conflicts of interests in the field of oncology and their impact on clinical practice.
This study illustrates the ability of 4π planning to improve cortical sparing and reduce radiation doses to standard brain OARS, white matter and the hippocampus in patients undergoing CNS radiotherapy.
This study is the first to provide an in depth look at Industry-related financial conflicts of interest in our field
This study uses diffusion models to characterize white matter changes after brain radiation to better understand the patho-physiology of radiation-induced tissue damage.